Pfizer agrees to buy Seagen for $43 billion
The drugmaker would pay $229 a share in cash for the biotech cancer specialist
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.